Workflow
INFUND HOLDING(002141)
icon
Search documents
动物保健板块8月13日跌0.53%,大禹生物领跌,主力资金净流出1.75亿元
Market Overview - The animal health sector experienced a decline of 0.53% on August 13, with Dayu Biological leading the drop [1] - The Shanghai Composite Index closed at 3683.46, up 0.48%, while the Shenzhen Component Index closed at 11551.36, up 1.76% [1] Individual Stock Performance - Key stocks in the animal health sector showed varied performance, with Xianfeng Holdings closing at 3.78, up 0.53%, and Dayu Biological closing at 9.84, down 3.15% [2][1] - Other notable stocks included Jinhe Biological at 7.45, down 3.12%, and Zhongmu Co. at 7.56, down 0.66% [2][1] Trading Volume and Value - The trading volume for Xianfeng Holdings was 268,700 shares with a transaction value of 102 million yuan, while Dayu Biological had a trading volume of 46,200 shares and a transaction value of 45.92 million yuan [2][1] Capital Flow Analysis - The animal health sector saw a net outflow of 175 million yuan from institutional investors, while retail investors contributed a net inflow of 143 million yuan [2][3] - The capital flow for specific stocks indicated that Hai Li Biological had a net inflow of 2.28 million yuan from institutional investors, while Xianfeng Holdings experienced a significant net outflow of 11.02 million yuan [3][2]
贤丰控股(002141)8月12日主力资金净流出1623.67万元
Sou Hu Cai Jing· 2025-08-12 10:28
金融界消息 截至2025年8月12日收盘,贤丰控股(002141)报收于3.76元,下跌1.83%,换手率2.47%, 成交量25.46万手,成交金额9576.60万元。 资金流向方面,今日主力资金净流出1623.67万元,占比成交额16.95%。其中,超大单净流出377.44万 元、占成交额3.94%,大单净流出1246.23万元、占成交额13.01%,中单净流出流出186.14万元、占成交 额1.94%,小单净流入1809.82万元、占成交额18.9%。 贤丰控股最新一期业绩显示,截至2025一季报,公司营业总收入2.95亿元、同比增长1669.88%,归属净 利润1421.01万元,同比增长9337.07%,扣非净利润345.65万元,同比增长60.21%,流动比率2.073、速 动比率1.881、资产负债率39.96%。 天眼查商业履历信息显示,贤丰控股股份有限公司,成立于2002年,位于珠海市,是一家以从事电气机 械和器材制造业为主的企业。企业注册资本103293.5798万人民币,实缴资本103293.5798万人民币。公 司法定代表人为韩桃子。 通过天眼查大数据分析,贤丰控股股份有限公司共对外投 ...
动物疫苗概念涨1.41%,主力资金净流入这些股
Core Insights - The animal vaccine sector saw a rise of 1.41%, ranking 8th among concept sectors, with 15 stocks increasing in value, led by Shenlian Bio, Kanghua Bio, and Tiankang Bio, which rose by 9.71%, 8.60%, and 2.02% respectively [1][2] - The sector experienced a net outflow of 6.53 million yuan in capital, with seven stocks receiving net inflows, primarily led by Guoyao Modern, which saw a net inflow of 29.79 million yuan [2][3] - The top three stocks by net inflow ratio were Guoyao Modern at 17.35%, Kexing Pharmaceutical at 9.18%, and Luoniushan at 9.02% [3] Stock Performance - Guoyao Modern had a daily increase of 1.35% with a turnover rate of 1.14% and a net capital flow of 29.79 million yuan [3] - Kexing Pharmaceutical increased by 0.54% with a turnover rate of 2.79% and a net capital flow of 24.08 million yuan [3] - Luoniushan rose by 1.11% with a turnover rate of 2.44% and a net capital flow of 16.07 million yuan [3] Declining Stocks - Xianfeng Holdings, Biotech Shares, and Yongshun Bio were among the stocks with the largest declines, falling by 3.05%, 1.04%, and 0.60% respectively [1][4] - Other notable declines included Tian Kang Bio at 2.02% and Ruipu Bio at 0.56% [4]
动物保健板块8月5日涨1.46%,申联生物领涨,主力资金净流入1.38亿元
Market Overview - The animal health sector increased by 1.46% on August 5, with Shenlian Biological leading the gains [1] - The Shanghai Composite Index closed at 3617.6, up 0.96%, while the Shenzhen Component Index closed at 11106.96, up 0.59% [1] Stock Performance - Shenlian Biological (688098) closed at 8.83, up 10.79% with a trading volume of 410,700 shares and a turnover of 348 million yuan [1] - Xianfeng Holdings (002141) closed at 3.81, up 4.10% with a trading volume of 732,700 shares and a turnover of 280 million yuan [1] - Jinhai Biological (002688) closed at 7.60, up 3.54% with a trading volume of 645,200 shares and a turnover of 487 million yuan [1] - Huisheng Biological (300871) closed at 24.82, up 1.85% with a trading volume of 260,400 shares and a turnover of 636 million yuan [1] Capital Flow - The animal health sector saw a net inflow of 138 million yuan from institutional investors, while retail investors experienced a net outflow of 127 million yuan [2] - The overall capital flow indicates a mixed sentiment, with institutional investors showing confidence while retail investors are withdrawing [2] Individual Stock Capital Flow - Jinhai Biological had a net inflow of 40.62 million yuan from institutional investors, while retail investors had a net outflow of 29.52 million yuan [3] - Huisheng Biological saw a net inflow of 36.65 million yuan from institutional investors, but a significant outflow of 74.58 million yuan from retail investors [3] - Shenlian Biological experienced a net inflow of 18.09 million yuan from institutional investors, with retail investors withdrawing 20.78 million yuan [3]
贤丰控股(002141.SZ):不具备人用疫苗的生产条件和研究条件
Ge Long Hui· 2025-08-05 07:55
Group 1 - The core viewpoint of the article is that Xianfeng Holdings (002141.SZ) clarifies that its products are primarily veterinary vaccines and not human vaccines, indicating that the company does not have the production and research conditions for human vaccines [1]
动物保健板块8月4日涨0.65%,生物股份领涨,主力资金净流入6812.16万元
Market Overview - The animal health sector increased by 0.65% on August 4, with BioShares leading the gains [1] - The Shanghai Composite Index closed at 3583.31, up 0.66%, while the Shenzhen Component Index closed at 11041.56, up 0.46% [1] Stock Performance - BioShares (600201) closed at 8.75, rising by 2.70% with a trading volume of 327,100 shares and a turnover of 280 million yuan [1] - Jinhe Biology (002688) closed at 7.34, up 2.51%, with a trading volume of 666,900 shares and a turnover of 485 million yuan [1] - Ruipu Biology (300119) closed at 21.58, increasing by 1.27%, with a trading volume of 72,800 shares and a turnover of 155 million yuan [1] - KQ Biology (688526) closed at 17.00, up 1.01%, with a trading volume of 29,600 shares and a turnover of 49.88 million yuan [1] - Other notable stocks include Dayu Biology (871970) at 10.40 (+0.97%) and Zeng Caike (603566) at 15.00 (+0.87%) [1] Capital Flow - The animal health sector saw a net inflow of 68.12 million yuan from institutional investors, while retail investors experienced a net outflow of 58.45 million yuan [2] - The main capital inflow and outflow for specific stocks include: - Jinhe Biology: 70.12 million yuan inflow from main investors, 33.36 million yuan outflow from retail investors [3] - BioShares: 15.45 million yuan inflow from main investors, 8.61 million yuan outflow from retail investors [3] - Shilian Biology (688098): 3.79 million yuan inflow from main investors, 27.89 million yuan outflow from retail investors [3]
动物疫苗概念涨2.22%,主力资金净流入6股
Group 1 - The animal vaccine sector experienced a rise of 2.22%, leading the concept sectors in terms of growth, with 13 stocks increasing in value, including Shenyuan Biological which hit the daily limit, and Yongshun Biological, Kexing Pharmaceutical, and Jinhai Biological showing notable gains of 6.32%, 4.08%, and 3.32% respectively [1][2] - The main inflow of funds into the animal vaccine sector amounted to a net inflow of 51 million yuan, with Kexing Pharmaceutical receiving the highest net inflow of 72.79 million yuan, followed by Shenyuan Biological, Kanghua Biological, and Xianfeng Holdings with net inflows of 57.81 million yuan, 46.82 million yuan, and 7.03 million yuan respectively [2][3] - The net inflow ratios for Shenyuan Biological, Xianfeng Holdings, and Kexing Pharmaceutical were 23.96%, 11.45%, and 9.02% respectively, indicating strong investor interest in these stocks [3] Group 2 - The animal vaccine sector's performance was contrasted by declines in other sectors, such as the China Shipbuilding System which fell by 2.54%, and the military equipment restructuring concept which decreased by 1.90% [2] - The trading volume and turnover rates for leading stocks in the animal vaccine sector were significant, with Shenyuan Biological showing a turnover rate of 7.26% and Kexing Pharmaceutical at 7.15% [3][4] - Several stocks within the animal vaccine sector experienced negative net inflows, including Guoyao Modern, Biological Shares, and Zhongmu Shares, which saw declines of 0.70%, 0.58%, and 0.52% respectively [1][4]
动物保健板块7月31日跌0.43%,大禹生物领跌,主力资金净流出1611.97万元
证券之星消息,7月31日动物保健板块较上一交易日下跌0.43%,大禹生物领跌。当日上证指数报收于 3573.21,下跌1.18%。深证成指报收于11009.77,下跌1.73%。动物保健板块个股涨跌见下表: 从资金流向上来看,当日动物保健板块主力资金净流出1611.97万元,游资资金净流出6281.9万元,散户 资金净流入7893.87万元。动物保健板块个股资金流向见下表: | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 300871 回盛生物 | | 6787.00万 | 7.85% | -4042.91万 | -4.68% | -2744.09万 | -3.17% | | 600201 | 生物股份 | 2619.98万 | 9.14% | -534.51万 | -1.86% | -2085.47万 | -7.28% | | 002868 *ST绿康 | | 940.97万 | 10.50% | -518.20 ...
动物保健板块7月30日跌0.46%,生物股份领跌,主力资金净流出1.58亿元
证券之星消息,7月30日动物保健板块较上一交易日下跌0.46%,生物股份领跌。当日上证指数报收于 3615.72,上涨0.17%。深证成指报收于11203.03,下跌0.77%。动物保健板块个股涨跌见下表: | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 871970 | 大禹生物 | 10.98 | 7.65% | 7.08万 | 7555.51万 | | | 002868 | *ST绿康 | 26.73 | 4.99% | 2.78万 | 7294.48万 | | | 839729 | 永顺生物 | 10.02 | 1.83% | 4.19万 | 4168.45万 | | | 300871 | 回盛生物 | 22.22 | 1.37% | 16.18万 | | 3.63亿 | | 002688 | 金河生物 | 7.22 | 0.84% | 42.68万 | | 3.06亿 | | 688098 | 申联生物 | 6.90 | 0.73% | 10.01万 | 6919.84 ...
贤丰控股今日大宗交易折价成交773.07万股,成交额2651.61万元
Xin Lang Cai Jing· 2025-07-29 09:02
7月29日,贤丰控股大宗交易成交773.07万股,成交额2651.61万元,占当日总成交额的10.88%,成交价3.43元,较市场收盘 价3.75元折价8.53%。 | 交易日期 | 证券代码 | 证券简称 | 成交价格 | 成交量 | 成交金额 | 买方营业部 | 卖方营业部 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | (元) | (万股/万份) | (万元) | | | | 2025-07-29 | 002141 | 贤丰控股 | 3.43 | 773.07 | 2,651.61 世纪证券有限责任 | | 中国银河证券股份 | | | | | | | | 公司东莞鸿福路证 | 有限公司深圳景田 | | | | | | | | 券营业部 | 证券营业部 | ...